REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 5 filers reported holding REVANCE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. | 55,422 | $487,159 | 0.09% |
| DnB Asset Management AS | 34,652 | $304,591 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 500 | $4,395 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 183 | $1,609 | 0.00% |
| Versant Capital Management, Inc | 62 | $545 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.